Pertuzumab Increases 17-AAG-Induced Degradation of ErbB2, and This Effect Is Further Increased by Combining Pertuzumab with Trastuzumab

ErbB2 is an important oncogenic protein involved in carcinogenesis of, among others, breast, gastric, and ovarian carcinoma. Over-expression of ErbB2 is found in almost 20% of breast cancers, and this results in proliferative and anti-apoptotic signalling. ErbB2 is therefore an important treatment t...

Descripción completa

Detalles Bibliográficos
Autores principales: Hughes, Juliana Bentes, Rødland, Marianne Skeie, Hasmann, Max, Madshus, Inger Helene, Stang, Espen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3763667/
https://www.ncbi.nlm.nih.gov/pubmed/24281706
http://dx.doi.org/10.3390/ph5070674

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3763667/
https://www.ncbi.nlm.nih.gov/pubmed/24281706
http://dx.doi.org/10.3390/ph5070674

Ejemplares similares